Search
In a conversational 30-minute forum over Zoom, Saul Ewing attorneys will host a monthly series discussing emerging industry developments and common issues that cannabis businesses face today. Interested in the full series? Learn more about additional dates and topics. For questions, please contact...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the first quarter of 2024. If you would like to discuss...
Lawyers Only: Making Litigation Funding Better What are the best practices for firms to seek working capital? How do firms recommend funders for their clients? How are law firms contemplating using funding or investment for cases after filing? How does one navigating the ethical, privilege...
Litigation Risk Insurance; New Coverages; Risk Solutions; and Nuclear Claims? Litigation risk insurance, which for the most part, insures against adverse judgments or assists in preserving judgments, has become popular in the last few years. What is litigation risk insurance? How is it underwritten...
Breaking (free from) the Bank: Cannabis Litigation Finance This panel provides an overview of litigation finance, explores unique aspects of cannabis litigation that make cannabis litigation finance necessary, and provides resources for cannabis attorneys and their clients as they explore litigation...
January 26, 2024 - With AI poised to reshape the practice of law and businesses in every industry, Saul Ewing is pleased to partner with the ABA’s Intellectual Property Litigation Committee in forming the AI Subcommittee. The AI Subcommittee will monitor legal and technological developments in this...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the fourth quarter of 2023. If you would like to discuss...
Panel 4: The Connections Between Insurance and Litigation Funding Join Partner Brian Michalek and the University of Chicago Center on Law and Finance , in sponsorship with Burford Capital and Alliant, at the 2023 Chicago Conference on Litigation Finance. This conference will explore the policy...
Saul Ewing’s Casey Grabenstein and Andrew Schwerin write that courts are divided on whether plaintiff bias justifies discovery about litigation funding. They argue litigation funding wouldn’t often create a conflict of interest for a plaintiff.
Contingent Liability Insurance Demystified Partner Brian Michalek will speak on a panel during the 2023 Transaction Solutions Symposium. More information to come.
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...
BOSTON, MA (February 7, 2023) – Jon Barooshian and Patrick Tracey bring a combined five decades of experience as litigators to their new roles as partners in the firm’s Boston office. Mr. Barooshian will focus his practice on white collar and government enforcement matters and tax controversies...
Overview (Program Summary) Alexander (Sandy) R. Bilus, Partner, Saul Ewing LLP, Cybersecurity and Privacy Co-Chair, will be the speaker. This session, sponsored by the Association of Corporate Counsel, will focus on the state privacy laws that are going into effect in 2023 as well as current...